Vemurafenib
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Vemurafenib Product Information
Vemurafenib is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Vemurafenib. The product is supplied by Clearsynth under CAT No. CS-O-10915.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Vemurafenib
CAS No.
918504-65-1
CAT No.
CS-O-10915
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C23H18ClF2N3O3S
Molecular Weight
489.92
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Vemurafenib is supplied with detailed characterization data compliant with regulatory guideline. Vemurafenib can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Vemurafenib.
Overview
"Vemurafenib selective BRAFV600E kinase inhibitor; an antitumor agent. Vemurafenib functions by inhibiting the proliferation and mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase and ERK phosphorylation in a panel of tumor cell lines, including melanoma cell lines expressing BRAFV600E or other mutant BRAF proteins altered at codon 600."
Synonyms
Vemurafenib
Application Notes
"Vemurafenib selective BRAFV600E kinase inhibitor; an antitumor agent. Vemurafenib functions by inhibiting the proliferation and mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase and ERK phosphorylation in a panel of tumor cell lines, including melanoma cell lines expressing BRAFV600E or other mutant BRAF proteins altered at codon 600."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.